Insulin Glargine (Lantus®)

DRUG2 trials

Sponsors

Pfizer, University Hospital Tuebingen

Conditions

Diabetes Mellitus, Type 2Type2 Diabetes Mellitus

Phase 4

A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®

CompletedNCT00391027

PfizerDiabetes Mellitus, Type 2

Start: 2006-12-31End: 2008-08-31Updated: 2015-07-23

Empagliflozin Effect on Glucose Toxicity

WithdrawnNCT03437330

University Hospital TuebingenType2 Diabetes Mellitus

Start: 2021-10-27End: 2023-05-03Updated: 2024-05-16